Bisphosphonate linked to atrial fibrillation
1 March 2010
| by Louise Wallace
An Australian specialist is warning practitioners to be cautious when using the bisphosphonate alendronate in patients with a history of cardiac arrhythmia after finding the drug was associated with a higher incidence of atrial fibrillation (AF)....
Want to read complete article? Please Sign in or Register.